[Ip-health] SouthViews: Creative imitation at the front of pharma biotechnology opportunities: some lessons from late late industrialization countries

Anna Bernardo Bernardo at southcentre.int
Fri Oct 30 08:53:02 PDT 2020


SouthViews 209, 30 October 2020

Creative imitation at the front of pharma biotechnology opportunities: some lessons from late late industrialization countries

By Pablo Lavarello and Sebastián Sztulwark

Given that high-cost biopharmaceutical drug patents have started to expire since the early 2000s, biotechnology opens up opportunities for developing countries to pursue an upgrading process by entering the sector as early imitators. Developing these opportunities was transformed on priority needs of health systems since the outbreak of COVID-19. Certain developing countries have advanced in a strategy of imitating biotechnological reference drugs once their patents have expired, opening a possibility for a catching up process.

https://www.southcentre.int/southviews-no-209-30-october-2020/


South Centre
Chemin du Champ d’Anier 17
PO Box 228
1211 Geneva 19
Switzerland
Telephone: (41 22) 791 8050
south at southcentre.int<mailto:south at southcentre.int>
https://www.southcentre.int/

Follow the South Centre's Twitter: https://twitter.com/South_Centre



More information about the Ip-health mailing list